i-Function and Lunavi Launch AI Platform for Early Cognitive Decline Detection

i-Function and Lunavi have launched the LASSI-D platform, an AI-enabled tool designed to detect Mild Cognitive Impairment (MCI) early, a condition that often precedes Alzheimer's disease. Announced in a press release, this innovative digital tool aims to replace traditional, costly, and time-consuming cognitive tests with a more accessible solution.

The LASSI-D platform is cloud-native and incorporates high-accuracy voice recognition, multilingual support, and automated scoring to identify subtle cognitive changes. It is designed for both clinical and remote use, making it a versatile tool for healthcare professionals. The platform's development was supported by research from the National Institutes of Health (NIH).

Lunavi played a crucial role in transforming the original paper-based LASSI-L assessment into this scalable digital solution. The company utilized a secure Microsoft Azure-based environment and integrated advanced speech-to-text technologies from Google and Azure to enhance voice recognition accuracy to over 99%. This collaboration highlights the potential of combining clinically validated methodologies with cutting-edge technology to improve health outcomes through earlier detection and intervention.